The management of Hodgkin's disease : Half a century of change : The Kaplan memorial lectureROSENBERG, S. A.Annals of oncology. 1996, Vol 7, Num 6, pp 555-560, issn 0923-7534Article

Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomasROSENBERG, S. A.Cancer treatment reports. 1984, Vol 68, Num 9, pp 1067-1078, issn 0361-5960Article

Progress in the development of immunotherapy for the treatment of patients with cancerROSENBERG, S. A.Journal of internal medicine. 2001, Vol 250, Num 6, pp 462-475, issn 0954-6820Article

Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigensROSENBERG, S. A.Journal of the National Cancer Institute. 1996, Vol 88, Num 22, pp 1635-1644, issn 0027-8874Article

Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's diseaseROSENBERG, S. A.European journal of cancer. Part A. 1992, Vol 28, Num 8-9, pp 1379-1380Conference Paper

The development of new immunotherapies for the treatment of cancer using interleukin-2ROSENBERG, S. A.Annals of surgery. 1988, Vol 208, Num 2, pp 121-135, issn 0003-4932Article

Adoptive immunotherapy of cancer: accomplishments and prospects = Immunothérapie adoptive du cancer: résultats et perspectivesROSENBERG, S. A.Cancer treatment reports. 1984, Vol 68, Num 1, pp 233-255, issn 0361-5960Article

The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigensROSENBERG, S. A.Annual review of medicine. 1996, Vol 47, pp 481-491, issn 0066-4219Article

Development of new immunologic approaches to cancer therapyROSENBERG, S. A.Blood purification. 1988, Vol 6, Num 2, pp 69-76, issn 0253-5068Article

Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty yearsROSENBERG, S. A.Scandinavian journal of haematology. 1985, Vol 34, Num 4, pp 289-292, issn 0036-553XArticle

Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cellsSUYU SHU; ROSENBERG, S. A.The Journal of immunology (1950). 1985, Vol 135, Num 4, pp 2895-2903, issn 0022-1767Article

Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with γ-interferon genesOGASAWARA, M; ROSENBERG, S. A.Cancer research (Baltimore). 1993, Vol 53, Num 15, pp 3561-3568, issn 0008-5472Article

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinomaLAFRENIERE, R; ROSENBERG, S. A.The Journal of immunology (1950). 1985, Vol 135, Num 6, pp 4273-4280, issn 0022-1767Article

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2LAFRENIERE, R; ROSENBERG, S. A.Cancer research (Baltimore). 1985, Vol 45, Num 8, pp 3735-3741, issn 0008-5472Article

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2MAZUMDER, A; ROSENBERG, S. A.The Journal of experimental medicine. 1984, Vol 159, Num 2, pp 495-507, issn 0022-1007Article

Tel bcl-2 gene, follicular lymphoma, and hodgkin's diseaseCLEARY, M; ROSENBERG, S. A.Journal of the National Cancer Institute. 1990, Vol 82, Num 10, pp 808-809, issn 0027-8874Article

Blocking by cyclosphorine of antigen-induced maturation and lymphokine secretion by cytotoxic T lymphocyte hybridomasKAUFMANN, Y; ROSENBERG, S. A.Transplantation. 1984, Vol 38, Num 2, pp 148-151, issn 0041-1337Article

Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies = Génération de clones lymphoïdes lytiques et prolifératifs vis-à-vis de tumeur syngénique: études in vitro et in vivoROSENSTEIN, M; ROSENBERG, S. A.Journal of the National Cancer Institute. 1984, Vol 72, Num 5, pp 1161-1165, issn 0027-8874Article

Immunotherapy and gene therapy of cancerROSENBERG, S. A.Cancer research (Baltimore). 1991, Vol 51, Num 18, pp 5074s-5079s, issn 0008-5472Conference Paper

Systemic induction of cells mediating antibody-dependent cellular cytotoxicity following administration of interleukin 2EISENTHAL, A; ROSENBERG, S. A.Cancer research (Baltimore). 1989, Vol 49, Num 24, pp 6953-6959, issn 0008-5472, part 1Article

A novel approach to the generation and identification of experimental hepatic metastases in a murine modelLAFRENIERE, R; ROSENBERG, S. A.Journal of the National Cancer Institute. 1986, Vol 76, Num 2, pp 309-322, issn 0027-8874Article

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trialADVANI, R. H; HOPPE, R. T; BAER, D et al.Annals of oncology. 2013, Vol 24, Num 4, pp 1044-1048, issn 0923-7534, 5 p.Article

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivoCORMIER, J. N; HIJAZI, Y. M; ABATI, A et al.International journal of cancer. 1998, Vol 75, Num 4, pp 517-524, issn 0020-7136Article

Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumorsZAKS, T. Z; ROSENBERG, S. A.Cancer research (Baltimore). 1998, Vol 58, Num 21, pp 4902-4908, issn 0008-5472Article

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigensROSENBERG, S. A; YIFAN ZHAI; ROBERTS, B et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 24, pp 1894-1900, issn 0027-8874Article